You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Fluoropolymer in Healthcare Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Fluoropolymers are fluorocarbon-based polymers formed by a strong bonding between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics and are characterized by high resistance to acids, bases, and solvents. Various fluoropolymer products such as polytetrafluoroethylene (PTFE), polyvinylidene difluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polychlorotrifluoroethylene (PCTFE), polyvinyl fluoride (PVF), ethylene chlorotrifluoroethylene (ECTFE), perfluoroalkoxy (PFA), and fluoroelastomers are commonly used in healthcare application.
The pharmaceutical packaging segment accounted for major shares of the fluoropolymer market. Fluoropolymers are widely used in the packaging of pharmaceutical products such as medical liquids, tablets, pills, and sprays. The enhanced moisture barrier properties of fluoropolymers make them suitable for the blister packaging of sensitive pharmaceutical products such as pills and powders.
The global Fluoropolymer in Healthcare market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Fluoropolymer in Healthcare production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Fluoropolymer in Healthcare by regions (countries) and by Application.
The global Fluoropolymer in Healthcare market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Fluoropolymer in Healthcare market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Fluoropolymer in Healthcare markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Fluoropolymer in Healthcare market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Fluoropolymer in Healthcare market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Fluoropolymer in Healthcare market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Fluoropolymer in Healthcare market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Fluoropolymer in Healthcare market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Fluoropolymer in Healthcare market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Fluoropolymer in Healthcare market by each application segment for the same period.
This report includes the following manufacturers:
Ashai Glass
Chemours Company
Daikin industry
3M (Dyneon)
Arkema
Daikin industry
Honeywell International
Dongyue Group
Chicago Gasket
Flontech USA
Solvay
Saint-Gobain
Mexichem
Zeus Industrial Products
W.L. Gore & Associates
Market Segment by Type
Polytetrafluoroethylene (PTFE)
Polyvinylidene Difluoride (PVDF)
Fluorinated Ethylene Propylene (FEP)
Ethylene Tetrafluoroethylene (ETFE)
Polyvinyl Fluoride (PVF)
Others
Market Segment by Application
Pharmaceutical Packaging
Medical Devices
Drug Delivery
Others
Research Methodology
To compile the detailed study of the global Fluoropolymer in Healthcare market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Fluoropolymer in Healthcare market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Fluoropolymer in Healthcare market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Fluoropolymer in Healthcare Market Size Growth Rate by Type
1.2.2 Polytetrafluoroethylene (PTFE)
1.2.3 Polyvinylidene Difluoride (PVDF)
1.2.4 Fluorinated Ethylene Propylene (FEP)
1.2.5 Ethylene Tetrafluoroethylene (ETFE)
1.2.6 Polyvinyl Fluoride (PVF)
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Fluoropolymer in Healthcare Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Pharmaceutical Packaging
1.3.3 Medical Devices
1.3.4 Drug Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Fluoropolymer in Healthcare Market Size (2016-2027)
2.1.1 Global Fluoropolymer in Healthcare Revenue (2016-2027)
2.1.2 Global Fluoropolymer in Healthcare Sales (2016-2027)
2.2 Global Fluoropolymer in Healthcare Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Fluoropolymer in Healthcare Sales by Regions (2016-2021)
2.2.2 Global Fluoropolymer in Healthcare Revenue by Regions (2016-2021)
2.3 Global Fluoropolymer in Healthcare Market Size Forecast by Region
2.3.1 Global Fluoropolymer in Healthcare Sales Forecast by Region (2022-2027)
2.3.2 Global Fluoropolymer in Healthcare Revenue Forecast by Region (2022-2027)
2.4 Global Top Fluoropolymer in Healthcare Regions (Countries) Ranking by Market Size
2.5 Fluoropolymer in Healthcare Industry Trends
2.5.1 Fluoropolymer in Healthcare Market Trends
2.5.2 Fluoropolymer in Healthcare Market Drivers
2.5.3 Fluoropolymer in Healthcare Market Challenges
2.5.4 Fluoropolymer in Healthcare Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Fluoropolymer in Healthcare Manufacturers by Sales (2016-2021)
3.1.1 Global Fluoropolymer in Healthcare Sales by Manufacturers (2016-2021)
3.1.2 Global Fluoropolymer in Healthcare Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Fluoropolymer in Healthcare Sales in 2020
3.2 Global Top Manufacturers Fluoropolymer in Healthcare by Revenue
3.2.1 Global Fluoropolymer in Healthcare Revenue by Manufacturers (2016-2021)
3.2.2 Top Fluoropolymer in Healthcare Manufacturers Covered: Ranking by Revenue
3.2.3 Global Fluoropolymer in Healthcare Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Fluoropolymer in Healthcare Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fluoropolymer in Healthcare as of 2020)
3.4 Global Fluoropolymer in Healthcare Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Fluoropolymer in Healthcare Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Fluoropolymer in Healthcare Market
3.7 Key Manufacturers Fluoropolymer in Healthcare Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Fluoropolymer in Healthcare Market Size by Type
4.1 Global Fluoropolymer in Healthcare Historic Market Review by Type (2016-2021)
4.1.1 Global Fluoropolymer in Healthcare Sales Market Share by Type (2016-2021)
4.1.2 Global Fluoropolymer in Healthcare Revenue Market Share by Type (2016-2021)
4.1.3 Fluoropolymer in Healthcare Price by Type (2016-2021)
4.2 Global Fluoropolymer in Healthcare Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Fluoropolymer in Healthcare Sales Forecast by Type (2022-2027)
4.2.2 Global Fluoropolymer in Healthcare Revenue Forecast by Type (2022-2027)
4.2.3 Fluoropolymer in Healthcare Price Forecast by Type (2022-2027)

5 Global Fluoropolymer in Healthcare Market Size by Application
5.1 Global Fluoropolymer in Healthcare Historic Market Review by Application (2016-2021)
5.1.1 Global Fluoropolymer in Healthcare Sales Market Share by Application (2016-2021)
5.1.2 Global Fluoropolymer in Healthcare Revenue Market Share by Application (2016-2021)
5.1.3 Fluoropolymer in Healthcare Price by Application (2016-2021)
5.2 Global Fluoropolymer in Healthcare Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Fluoropolymer in Healthcare Sales Forecast by Application (2022-2027)
5.2.2 Global Fluoropolymer in Healthcare Revenue Forecast by Application (2022-2027)
5.2.3 Fluoropolymer in Healthcare Price Forecast by Application (2022-2027)

6 North America
6.1 North America Fluoropolymer in Healthcare Sales Breakdown by Company
6.1.1 North America Fluoropolymer in Healthcare Sales by Company (2016-2027)
6.1.2 North America Fluoropolymer in Healthcare Revenue by Company (2016-2027)
6.2 North America Fluoropolymer in Healthcare Market Size by Type (2016-2027)
6.2.1 North America Fluoropolymer in Healthcare Sales by Type (2016-2027)
6.2.2 North America Fluoropolymer in Healthcare Revenue by Type (2016-2027)
6.3 North America Fluoropolymer in Healthcare Market Size by Application (2016-2027)
6.3.1 North America Fluoropolymer in Healthcare Sales by Application (2016-2027)
6.3.2 North America Fluoropolymer in Healthcare Revenue by Application (2016-2027)
6.4 North America Fluoropolymer in Healthcare Market Size by Country
6.4.1 North America Fluoropolymer in Healthcare Sales by Country (2016-2027)
6.4.2 North America Fluoropolymer in Healthcare Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Fluoropolymer in Healthcare Sales Breakdown by Company
7.1.1 Europe Fluoropolymer in Healthcare Sales by Company (2016-2027)
7.1.2 Europe Fluoropolymer in Healthcare Revenue by Company (2016-2027)
7.2 Europe Fluoropolymer in Healthcare Market Size by Type (2016-2027)
7.2.1 Europe Fluoropolymer in Healthcare Sales by Type (2016-2027)
7.2.2 Europe Fluoropolymer in Healthcare Revenue by Type (2016-2027)
7.3 Europe Fluoropolymer in Healthcare Market Size by Application (2016-2027)
7.3.1 Europe Fluoropolymer in Healthcare Sales by Application (2016-2027)
7.3.2 Europe Fluoropolymer in Healthcare Revenue by Application (2016-2027)
7.4 Europe Fluoropolymer in Healthcare Market Size by Country
7.4.1 Europe Fluoropolymer in Healthcare Sales by Country (2016-2027)
7.4.2 Europe Fluoropolymer in Healthcare Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Fluoropolymer in Healthcare Sales Breakdown by Company
8.1.1 Asia Pacific Fluoropolymer in Healthcare Sales by Company (2016-2027)
8.1.2 Asia Pacific Fluoropolymer in Healthcare Revenue by Company (2016-2027)
8.2 Asia Pacific Fluoropolymer in Healthcare Market Size by Type (2016-2027)
8.2.1 Asia Pacific Fluoropolymer in Healthcare Sales by Type (2016-2027)
8.2.2 Asia Pacific Fluoropolymer in Healthcare Revenue by Type (2016-2027)
8.3 Asia Pacific Fluoropolymer in Healthcare Market Size by Application (2016-2027)
8.3.1 Asia Pacific Fluoropolymer in Healthcare Sales by Application (2016-2027)
8.3.2 Asia Pacific Fluoropolymer in Healthcare Revenue by Application (2016-2027)
8.4 Asia Pacific Fluoropolymer in Healthcare Market Size by Regions
8.4.1 Asia Pacific Fluoropolymer in Healthcare Sales by Regions
8.4.2 Asia Pacific Fluoropolymer in Healthcare Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Fluoropolymer in Healthcare Sales Breakdown by Company
9.1.1 Latin America Fluoropolymer in Healthcare Sales by Company (2016-2027)
9.1.2 Latin America Fluoropolymer in Healthcare Revenue by Company (2016-2027)
9.2 Latin America Fluoropolymer in Healthcare Market Size by Type (2016-2027)
9.2.1 Latin America Fluoropolymer in Healthcare Sales by Type (2016-2027)
9.2.2 Latin America Fluoropolymer in Healthcare Revenue by Type (2016-2027)
9.3 Latin America Fluoropolymer in Healthcare Market Size by Application (2016-2027)
9.3.1 Latin America Fluoropolymer in Healthcare Sales by Application (2016-2027)
9.3.2 Latin America Fluoropolymer in Healthcare Revenue by Application (2016-2027)
9.4 Latin America Fluoropolymer in Healthcare Market Size by Country
9.4.1 Latin America Fluoropolymer in Healthcare Sales by Country (2016-2027)
9.4.2 Latin America Fluoropolymer in Healthcare Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Fluoropolymer in Healthcare Sales Breakdown by Company
10.1.1 Middle East and Africa Fluoropolymer in Healthcare Sales by Company (2016-2027)
10.1.2 Middle East and Africa Fluoropolymer in Healthcare Revenue by Company (2016-2027)
10.2 Middle East and Africa Fluoropolymer in Healthcare Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Fluoropolymer in Healthcare Sales by Type (2016-2027)
10.2.2 Middle East and Africa Fluoropolymer in Healthcare Revenue by Type (2016-2027)
10.3 Middle East and Africa Fluoropolymer in Healthcare Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Fluoropolymer in Healthcare Sales by Application (2016-2027)
10.3.2 Middle East and Africa Fluoropolymer in Healthcare Revenue by Application (2016-2027)
10.4 Middle East and Africa Fluoropolymer in Healthcare Market Size by Country
10.4.1 Middle East and Africa Fluoropolymer in Healthcare Sales by Country (2016-2027)
10.4.2 Middle East and Africa Fluoropolymer in Healthcare Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Ashai Glass
11.1.1 Ashai Glass Corporation Information
11.1.2 Ashai Glass Overview
11.1.3 Ashai Glass Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Ashai Glass Fluoropolymer in Healthcare Products and Services
11.1.5 Ashai Glass Fluoropolymer in Healthcare SWOT Analysis
11.1.6 Ashai Glass Recent Developments
11.2 Chemours Company
11.2.1 Chemours Company Corporation Information
11.2.2 Chemours Company Overview
11.2.3 Chemours Company Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Chemours Company Fluoropolymer in Healthcare Products and Services
11.2.5 Chemours Company Fluoropolymer in Healthcare SWOT Analysis
11.2.6 Chemours Company Recent Developments
11.3 Daikin industry
11.3.1 Daikin industry Corporation Information
11.3.2 Daikin industry Overview
11.3.3 Daikin industry Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Daikin industry Fluoropolymer in Healthcare Products and Services
11.3.5 Daikin industry Fluoropolymer in Healthcare SWOT Analysis
11.3.6 Daikin industry Recent Developments
11.4 3M (Dyneon)
11.4.1 3M (Dyneon) Corporation Information
11.4.2 3M (Dyneon) Overview
11.4.3 3M (Dyneon) Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 3M (Dyneon) Fluoropolymer in Healthcare Products and Services
11.4.5 3M (Dyneon) Fluoropolymer in Healthcare SWOT Analysis
11.4.6 3M (Dyneon) Recent Developments
11.5 Arkema
11.5.1 Arkema Corporation Information
11.5.2 Arkema Overview
11.5.3 Arkema Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Arkema Fluoropolymer in Healthcare Products and Services
11.5.5 Arkema Fluoropolymer in Healthcare SWOT Analysis
11.5.6 Arkema Recent Developments
11.6 Daikin industry
11.6.1 Daikin industry Corporation Information
11.6.2 Daikin industry Overview
11.6.3 Daikin industry Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Daikin industry Fluoropolymer in Healthcare Products and Services
11.6.5 Daikin industry Fluoropolymer in Healthcare SWOT Analysis
11.6.6 Daikin industry Recent Developments
11.7 Honeywell International
11.7.1 Honeywell International Corporation Information
11.7.2 Honeywell International Overview
11.7.3 Honeywell International Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Honeywell International Fluoropolymer in Healthcare Products and Services
11.7.5 Honeywell International Fluoropolymer in Healthcare SWOT Analysis
11.7.6 Honeywell International Recent Developments
11.8 Dongyue Group
11.8.1 Dongyue Group Corporation Information
11.8.2 Dongyue Group Overview
11.8.3 Dongyue Group Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Dongyue Group Fluoropolymer in Healthcare Products and Services
11.8.5 Dongyue Group Fluoropolymer in Healthcare SWOT Analysis
11.8.6 Dongyue Group Recent Developments
11.9 Chicago Gasket
11.9.1 Chicago Gasket Corporation Information
11.9.2 Chicago Gasket Overview
11.9.3 Chicago Gasket Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Chicago Gasket Fluoropolymer in Healthcare Products and Services
11.9.5 Chicago Gasket Fluoropolymer in Healthcare SWOT Analysis
11.9.6 Chicago Gasket Recent Developments
11.10 Flontech USA
11.10.1 Flontech USA Corporation Information
11.10.2 Flontech USA Overview
11.10.3 Flontech USA Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Flontech USA Fluoropolymer in Healthcare Products and Services
11.10.5 Flontech USA Fluoropolymer in Healthcare SWOT Analysis
11.10.6 Flontech USA Recent Developments
11.11 Solvay
11.11.1 Solvay Corporation Information
11.11.2 Solvay Overview
11.11.3 Solvay Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Solvay Fluoropolymer in Healthcare Products and Services
11.11.5 Solvay Recent Developments
11.12 Saint-Gobain
11.12.1 Saint-Gobain Corporation Information
11.12.2 Saint-Gobain Overview
11.12.3 Saint-Gobain Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Saint-Gobain Fluoropolymer in Healthcare Products and Services
11.12.5 Saint-Gobain Recent Developments
11.13 Mexichem
11.13.1 Mexichem Corporation Information
11.13.2 Mexichem Overview
11.13.3 Mexichem Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Mexichem Fluoropolymer in Healthcare Products and Services
11.13.5 Mexichem Recent Developments
11.14 Zeus Industrial Products
11.14.1 Zeus Industrial Products Corporation Information
11.14.2 Zeus Industrial Products Overview
11.14.3 Zeus Industrial Products Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Zeus Industrial Products Fluoropolymer in Healthcare Products and Services
11.14.5 Zeus Industrial Products Recent Developments
11.15 W.L. Gore & Associates
11.15.1 W.L. Gore & Associates Corporation Information
11.15.2 W.L. Gore & Associates Overview
11.15.3 W.L. Gore & Associates Fluoropolymer in Healthcare Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 W.L. Gore & Associates Fluoropolymer in Healthcare Products and Services
11.15.5 W.L. Gore & Associates Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Fluoropolymer in Healthcare Value Chain Analysis
12.2 Fluoropolymer in Healthcare Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fluoropolymer in Healthcare Production Mode & Process
12.4 Fluoropolymer in Healthcare Sales and Marketing
12.4.1 Fluoropolymer in Healthcare Sales Channels
12.4.2 Fluoropolymer in Healthcare Distributors
12.5 Fluoropolymer in Healthcare Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 135